Genfit S.A. (GNFTF)
OTCMKTS
· Delayed Price · Currency is USD
3.320
0.00 (0.00%)
At close: Dec 19, 2024
Genfit Employees
Genfit had 159 employees as of December 31, 2023. The number of employees increased by 11 or 7.43% compared to the previous year.
Employees
159
Change (1Y)
11
Growth (1Y)
7.43%
Revenue / Employee
$510,208
Profits / Employee
$141,199
Market Cap
180.28M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Sandoz Group AG | 22,633 |
Telix Pharmaceuticals Limited | 234 |
Elekta AB (publ) | 4,718 |
Ryman Healthcare Limited | 7,700 |
Verano Holdings Corp. | 3,900 |
Vireo Growth Inc. | 490 |
Medexus Pharmaceuticals Inc. | 82 |
Genfit News
- 6 weeks ago - GENFIT Announces Corporate Updates and Upcoming Participation at The Liver Meeting® 2024 - GlobeNewsWire
- 6 weeks ago - Genfit reports 9M results - Seeking Alpha
- 6 weeks ago - GENFIT Reports Third Quarter 2024 Financial Information - GlobeNewsWire
- 3 months ago - Top 4 Health Care Stocks That May Keep You Up At Night - Benzinga
- 3 months ago - GENFIT: Ipsen's Iqirvo® (Elafibranor) Receives EU Approval as a First-in-Class Treatment for Primary Biliary Cholangitis following U.S. FDA Accelerated Approval - GlobeNewsWire
- 3 months ago - Genfit GAAP EPS of €0.53, revenue of €61.2M - Seeking Alpha
- 5 months ago - GENFIT: Positive Opinion from EMA Committee for Ipsen's Iqirvo® (elafibranor) in Primary Biliary Cholangitis - GlobeNewsWire
- 6 months ago - GENFIT: Half-Year Report of Liquidity Contract with Crédit Industriel et Commercial - GlobeNewsWire